Lambo, Rogelio T.

HRN: 10-66-25  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/06/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
06/06/2025
06/12/2025
IV
500mg
Q24h
HAP
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Pneumonia    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: